Episodic ataxia and channelopathies (Q41734804)

8 October 2017

1 reference

title

Episodic ataxia and channelopathies (English)

1 reference

8 October 2017

1 reference

Gordon N

1

1 reference

8 October 2017

publication date

1 January 1998

1 reference

8 October 2017

published in

Brain and Development

1 reference

8 October 2017

volume

20

1 reference

8 October 2017

issue

1

1 reference

8 October 2017

page(s)

9-13

1 reference

Episodic ataxias as channelopathies

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Autosomal dominant episodic ataxia: a heterogeneous syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Familial paroxysmal kinesigenic ataxia and continuous myokymia

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Mapping the gene for acetazolamide responsive hereditary paryoxysmal cerebellar ataxia to chromosome 19p

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Acetazolamide-responsive episodic ataxia in an Italian family refines gene mapping on chromosome 19p13.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Acetazolamide-responsive vestibulocerebellar syndrome: clinical and oculographic features

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Eye movements in a familial vestibulocerebellar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Familial hemiplegic migraine, nystagmus, and cerebellar atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Acetazolamide responsiveness in familial hemiplegic migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Local cholinergic mechanisms participate in the increase in cortical cerebral blood flow elicited by electrical stimulation of the fastigial nucleus in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Familial migraine with vertigo and essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Subacute Necrotizing Encephalomyelopathy (Leigh's Disease): a Consideration of Clinical Features and Etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Variable clinical presentation in patients with defective E1 component of pyruvate dehydrogenase complex

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Episodic weakness in pyruvate decarboxylase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Heredopathia atactica polyneuritiformis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Intermittent dystonia in Hartnup disease

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Recent advances in heritable ataxias

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

A possible mechanism for selective cerebellar damage in partial pyruvate dehydrogenase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Low Activities of the Pyruvate and Oxoglutarate Dehydrogenase Complexes in Five Patients with Friedreich's Ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Hereditary paroxysmal ataxia: Response to acetazolamide

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Ion channel shake-down.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Identification of two new KCNA1 mutations in episodic ataxia/myokymia families

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Episodic ataxia results from voltage-dependent potassium channels with altered functions

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Serotonin metabolism in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900086-7

7 January 2021

10.1016/S0387-7604(97)00086-7

Identifiers

DOI

1 reference

8 October 2017

1 reference